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ABSTRACT 
 This longitudinal study was the first study to assess the effect of two different kinds 
of exercise on levels of proinflammatory cytokines in PBMC and serum. IL-1β, TNF-α and 
IL-6 levels were measured using regular ELISA assay in PBMC; IL-6 was also measured in 
the serum using a high sensitivity ELISA kit. Physical activity measures and BMI was 
compared to assess the aerobic capacity, flexibility and effect of body weight on cytokine 
levels, with exercise. 
 There was a reduction seen in both the FLEX (strength and flexibility) and CARDIO 
(cardiovascular exercise) groups over ten months. There was a reduction in the IL-6 level in 
the CARDIO group, while there was an increase in the FLEX group. There were no changes 
in the TNF- α levels in either of the groups. No change in the serum cytokine levels in either 
group, a trend was seen in the CARDIO group. These results suggest that cardiovascular 
exercise may have a positive role in reducing the inflammatory effects of aging in an elderly 
population. 
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CHAPTER 1.  INTRODUCTION 
 Cytokines are diverse and potent chemical messengers in the range of 5-20 kD 
secreted by the cells of the immune system. A number of cytokines are grouped as ‘pro-
inflammatory’ as they accelerate inflammation and regulate inflammatory reactions either 
directly or by the induction of other inflammatory cytokines. Some of the major pro-
inflammatory cytokines include Interleukin-1 alpha (IL-1α), Interleukin-1 beta (IL1-β), 
Interleukin-6 (IL-6) and Tumor necrosis factor-alpha (TNF-α).1  They are released in 
response to stimuli such as signals from receptors (toll like receptors), or other cytokines  and 
may initiate an inflammatory cascade.  Other cytokines often considered to be anti-
inflammatory include IL-1RA, IL-4 and IL-10 and may be involved in the resolution of an 
inflammatory response.  In contrast, prolonged release of pro-inflammatory cytokines may 
result in tissue damage and continued inflammation.45 The proinflammatory and anti-
inflammatory cytokines maintain a balance until the homeostatic balance is disturbed.45 
 Recent evidence suggests that several chronic diseases such as Type II diabetes, 
cardiovascular disease, arthritis, obesity and osteoporosis are associated with increased levels 
of pro-inflammatory cytokines.2,3 The ‘inflammation hypothesis of aging’4,5 suggests that 
inflammation contributes to or potentially causes the aging process. As much as a four-fold 
increase in the serum levels of the pro-inflammatory cytokines may occur with aging.1 
Studies comparing younger and older age groups of people show increased levels of pro-
inflammatory cytokines in the elderly akin to a state of low grade inflammation.1 
 In contrast to the long-term low to moderate release of pro-inflammatory cytokines 
associated with chronic disease, a shorter increased release of proinflammatory cytokines is 
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associated with the acute phase response. As part of the inflammatory process, these locally 
released proinflammatory cytokines may stimulate the hepatocytes to release acute phase 
proteins such as C-reactive protein (CRP), transferrin and α-macroglobulin.6  Injection of 
TNF-α, IL-1β and IL-6 in normal individuals has been shown to cause increased release of 
CRP and the acute phase proteins.6 The acute phase response occurs a short time after injury, 
infection or inflammation and may be induced by stimuli that are infectious (bacterial, 
fungal, viral), trauma, or stress related. The cardinal signs characterizing an inflammatory 
response are localized redness (rubor), swelling (tumor), heat (calor) and pain (dolor). The 
acute phase proteins are further involved in the activation of leucocytes, fibroblasts, 
endothelial and smooth muscle cells causing the release of inflammatory cytokines. With 
chronic and recurrent infection or injury, the acute phase proteins may cause complications 
such as tissue damage and further disease affecting the central nervous system and the 
cardiovascular system.7  Acute exercise results in increased circulating levels of 
proinflammatory cytokines.9,10  Exercise may be broadly classified according to the type of 
muscle activity. Concentric exercise describes a shortening of the muscle (the ends of the 
muscle come closer) as force is exerted, whereas eccentric muscle action involves force that 
pulls the origin and insertion apart.  Acute exercise generally refers to a single session of 
exercise.  In contrast, chronic exercise occurs over a period of time (typically weeks to 
months).  Acute and chronic exercise appears to have differing effects on circulating levels of 
proinflammatory cytokines.  Acute exercise typically does not cause an exaggerated increase 
in the levels of proinflammatory cytokines as seen in acute trauma or disease. Two previous 
studies29,46 have shown an increase in the plasma levels of IL-1β, but other later studies show 
no increase,30 or a minimal increase9 in the levels of plasma IL-1β with a single exercise 
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session. Studies have also shown a one to two fold increase in the plasma9,10 levels of TNF-α 
with acute exercise; a study by Ullum et al. however showed no change in the plasma levels 
with a single session of eccentric exercise.31 The most consistent finding however is a 
marked increase in plasma IL-6 levels, immediately after acute exercise. 9,10,11,31 The extent to 
which IL-6 increases with exercise seems to depend on the duration and the intensity of 
exercise.  Higher exercise intensities result in greater increases in IL-6 levels.12 Though the 
increase in the IL-6 levels are rapid and typically peak immediately after the exercise session, 
these levels return to pre-exercise levels 2-4 hours after the cessation of exercise. 
 In contrast to acute exercise that causes a temporary increase in levels of 
proinflammatory cytokines, chronic exercise training may reduce the levels of 
proinflammatory cytokines, although data is limited. Previous studies have shown an inverse 
association between levels of inflammation (as measured by serum and plasma levels of 
cytokines) and aerobic physical activity.13,14,15,16 One study evaluated the effect of  exercise 
intervention on levels of pro-inflammatory cytokine produced by lipopolysaccharide (LPS)-
stimulated peripheral blood mononuclear cells (PBMC). In this exercise intervention study 
by Smith et.al17 a 60% reduction in PBMC production of proinflammatory cytokines TNF-α, 
IL-1β and IFN-γ (another proinflammatory cytokine) was found among middle age adults. If 
exercise can reduce the levels of pro-inflammatory cytokines in an older population, it is 
possible that the risk for developing multiple age-related diseases that are associated with 
elevated cytokines may be reduced.    To our knowledge, no study has yet evaluated whether 
long-term exercise intervention may reduce the levels of pro-inflammatory cytokines in an 
older population (a population that most likely shows some signs of inflammatory aging). In 
addition, aerobic exercise has not been compared with strength/ flexibility exercises to 
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determine if one type of exercise has a greater impact on proinflammatory cytokines in older 
adults. The purpose of our study was to determine the effect of aerobic training compared to 
strength/flexibility training on the levels of serum cytokine and lipopolysaccharide (LPS)-
induced cytokine release by peripheral blood mononuclear cells. We hypothesized that the 
levels of pro-inflammatory cytokines would decrease after aerobic exercise training to a 
greater extent than after strength/flexibility exercise intervention. The mechanisms for the 
change in proinflammatory cytokine levels are not examined in this study. Changes in body 
weight may also contribute to a change in pro-inflammatory cytokines and therefore, the 
analysis was designed to account for body weight.  
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CHAPTER 2. LITERATURE REVIEW 
Proinflammatory Cytokines 
Interleukin-1 (IL-1β) 
 The human IL-1β has been found close to IL-1α on the long arm of chromosome 2,18 
and is part of the Ig superfamily. It is a polypeptide and two genes for IL-1 (IL-1α and IL-1β) 
have been found. IL-1β is secreted by activated antigen presenting cells i.e macrophages, 
dendritic cells and B cells. IL-1β is pleiotropic in action (i.e multiple actions and effects) and 
plays a pivotal role in the body’s response to infection, involved in both innate and adaptive 
immunity. Apart from co-stimulating the activation of T helper cells, IL-1β promotes 
maturation and clonal expansion of B cells and may enhance NK cell activity.20 T helper 
cells, B cells, NK cells are target cells for IL-1β. IL-1β functions to attract macrophages and 
neutrophils, causing an accumulation of phagocytic cells during an inflammatory reaction.  
 In addition to the effects of IL-1 on T cells, B cells and NK cells, IL-1β has other 
biological actions.  For example,  IL-1β is known to be a potent pyrogen with regards to the 
central nervous system.20 IL-1β may also stimulate prostaglandin synthesis. Prostaglandins 
are produced and released by leucocytes at the site of injury; they are chemical compounds 
that activate the inflammatory response and induce symptoms of pain and fever. The 
biological properties of IL-1β may mimic host responses to infection, inflammation, injury or 
an immunological challenge. The effects of IL-1β have also been shown to mediate catabolic 
processes many days after an inflammatory stimulus. In vivo experiments have shown that 
similar to TNF-α and IL-6, IL-1β has a role in protein catabolism. IL-1β works 
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synergistically with other cytokines especially tumor necrosis factor in the inflammatory 
process.  
 
Interleukin-6 (IL-6) 
 IL-6 is a glycoprotein and part of the IL-6 superfamily. It is found on the long arm of 
chromosome 7. Like IL-1β, IL-6 is a pleiotropic cytokine with multiple functions. IL-6 
receptors are found in B cells, T cells, osteocytes, partially committed bone marrow cells and 
tumor cells. IL-6 is secreted by monocytes, macrophages, bone marrow stromal cells and T 
helper 2 cells. Some of the target cells for IL-6 may be activated B cells, plasma cells, and 
stem cells.20  IL-6 varies in its effects to inhibit growth of the cell, or promote differentiation 
of the cell.  For example, IL-6 may act as a modulator of bone re-absorption, as a promoter of 
hematopoiesis, and in inducing plasma cell development.21 IL-6 promotes terminal 
differentiation of B cells into plasma cells, stimulates antibody production, drives 
differentiation of myeloid stem cells and helps in the synthesis of acute phase proteins. IL-6 
has an important role as a co-stimulatory factor for mitogen or antigen induced T cell 
activation.  Lipopolysaccharide (LPS) enhances production of IL-6 in monocytes and 
fibroblasts, while glucocorticoids inhibit it.  In addition to its effects on the immune 
response, IL-6 is known to affect other tissues.  IL-6 may induce the release of 
adrenocorticotropic hormone (ACTH) production in the anterior pituitary  and subsequent 
release of glucocorticoids.21 IL-6 produced by the contracting muscle may have a role in 
hepatic regulation of glucose, consequent to depletion caused by exercise,33 acting directly on 
hepatocytes in the liver to release glycogen.  IL-6 is also expressed by adipose tissue. In 
healthy men and women, increased levels of adipose tissue have been related to increased 
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levels of circulating IL-6.47 Higher levels of IL-6 may also be expressed by the hypothalamic 
nuclei and its receptors, involved in body fat regulation.56 Therefore, the increased level of 
circulating IL-6 from adipose tissue suggests that obesity resembles a low-grade state of 
inflammation. Multiple chronic disease conditions have now been associated with elevated 
serum IL-6 including diabetes, atherosclerosis, hypertension and metabolic syndrome.  The 
elevated IL-6 levels in serum may reflect spillover from local tissue sites, but this remains to 
be established.  
 
Tumor necrosis factor (TNF-α) 
 The gene for TNF-α is found on the short arm of chromosome 6 and contains five 
exons with a length of about 5 kb. It was first identified as an anti-tumor agent that caused 
cell death in various tumor types.20 TNF-α is a potent proinflammatory cytokine and is part 
of the TNF super-family.24 TNF-α is produced by mononuclear phagocytes, T-lymphocytes, 
Kupffer cells, glial cells, mast cells and endothelial cells. TNF-α also causes B and T 
lymphocyte proliferation. LPS, antibodies, oxygen radicals, parasites, and irradiation are 
some of the stimuli that trigger production of TNF-α.61 Receptors for TNF-α are present in 
all human cells except red blood cells. Production of TNF-α in the body is tightly regulated; 
systemic overproduction may causes inflammatory responses such as septic shock.61 Higher 
levels of TNF-α produced locally and persisting over time may cause tissue injury.61  In 
contrast, shorter term local low levels of TNF-α help in tissue repair and regeneration61. TNF 
also acts as an inflammatory mediator with regard to other proinflammatory cytokines. While 
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TNF-α induces production of IL-1 and IL-6, the effects of TNF-α on inflammation are 
intensified when other proinflammatory cytokines such as IL-1 and IL-6 are present. 
 Increased TNF-α levels may also have some impact on heart disease.62 Higher levels 
of TNF-α are related to hypertension, higher levels of circulating triglycerides and 
endothelial cell activation in the artery walls. The endothelial cell activation leads to 
expression of chemokines and adhesion molecules, attracting leukocytes to the site.  Other 
tissues may produce TNF-α, resulting in systemic effects.  For example, TNF-α is produced 
by adipose tissue and stimulates lipolysis. Tissue wasting associated with several disease 
states is generally considered to result from the actions of TNF-α24.  
 
Disease and Proinflammatory Cytokines 
Interleukin-1 (IL-1β) 
 IL-1 is considered to be a major mediator of inflammation and is a key to many host 
defense responses. During normal homeostasis when the body is not infected, a balance 
exists between the levels of IL-1 and the receptor antagonist IL-1Ra. In conditions such as 
infection or disease there is an increase in the level of the proinflammatory cytokine IL-1β; 
higher levels of IL-1β stimulate the production of IL-1Ra. Even though IL-1Ra is produced 
by the liver to balance the actions of IL-1, higher levels of IL-1β are produced by the body in 
disease.20 Higher levels of IL-1β may be seen in autoimmune disorders, bacterial and viral 
infections; the increase in IL-1β may be either due to over production of IL-1β or inadequate 
levels of IL-1Ra.20  
 IL-1β may be elevated in autoimmune diseases such as osteoarthritis and rheumatoid 
arthritis. In rheumatoid arthritis, increased levels of IL-1β are found in the synovium and 
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synovial fluid, causing breakdown of the cartilaginous matrix.20 Higher levels of IL-1β are 
seen in neurological disorders like Guillian-Barre΄ syndrome and multiple sclerosis affecting 
the peripheral nervous system and the central nervous system respectively.20 Increased levels 
of IL-1β may be found in conditions such as trauma, malignancy, tuberculosis, pneumonia 
cystic fibrosis, sepsis, sarcoidosis, psoriasis and dermatitis.20 
 The proinflammatory cytokine IL-1β may also play a role in atherosclerosis. IL-
1β induces expression of adhesion molecules on endothelial cell surfaces in the arteries. The 
leucocytes that accumulate in the lumen release cytokines further amplifying the 
inflammatory response. This leads to smooth muscle cell proliferation and formation of a 
fibrous cap in the lumen of the vessel. As a result, formation of plaques may occur in the 
blood vessels that may cause symptoms of stroke and heart disease.20 
 
Interleukin-6 (IL-6) 
 Higher levels of IL-6 are found in most inflammatory diseases. Like IL-1β, increased 
levels of IL-6 have been associated with the inflammatory cascade of atherosclerosis. 
Cytokines and their receptors play an important role in the initiation and the perpetuation of 
the disease. Ikonomidis et.al25 found high plasma levels of IL-6 were found in patients with 
stable angina; the levels of IL-6 were directly proportional to the severity of artery disease. 
Studies have also shown an increase in proinflammatory cytokines in obese individuals, 
smokers and in non-insulin dependent diabetes mellitus.2 Higher levels of CRP and IL-6 are 
both known to be associated with Type II-Diabetes Mellitus (DM),2 suggesting that Type-II 
DM involves inflammation. Work by Pradhan et.al26 showed IL-6 to be a systemic 
inflammatory marker for risk of type-II DM. Spranger and Kroke et.al also concluded that 
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there was a three fold higher risk of developing DM with elevated levels of IL-6 and IL-1β 
together than just IL-1β alone.27 The study showed that proinflammatory cytokines work as a 
network in stimulating the acute phase proteins, which further have a role in the 
inflammatory process seen in DM. In addition, hyperglycemia may be associated with an 
acute increase in levels of inflammatory cytokines such as IL-6 in hyperglycemia perhaps as 
a result of oxidative stress.  Other studies have shown  a link between the levels of pro-
inflammatory cytokines in the blood and the levels in adipose tissue.28 Higher levels of pro-
inflammatory cytokine like IL-6 are seen in various neurodegenerative diseases like 
Parkinson’s disease and Alzheimer’s disease.60 Elevated IL-6 is also seen along with other 
proinflammatory cytokines in various kinds of degenerative conditions like arthritis.20 
Elevated levels of IL-6 are typically found in many autoimmune diseases such as rheumatoid 
arthritis encephalomyelitis, cancer and Diabetes Mellitus and levels depend on the extent and 
severity of the disease. 
 
Tumor necrosis factor-α (TNF-α) 
 Elevated levels of TNF-α are found in many disease conditions. Elevated levels of 
TNF-α are associated with atherosclerosis. In a study comparing symptoms of disease in 181 
elderly subjects by Bruunsgaard et al, higher levels of TNF-α were related to a higher risk of 
atherosclerosis and heart disease.28 Elevated levels of TNF-α have been seen in heart diseases 
such as left ventricular failure, cardiomyopathy and pulmonary edema.20 In addition to the 
potential role in heart disease, TNF-α also has a role in the regulation of adipose tissue. TNF-
α stimulates leptin production by adipose tissue. Leptin has a role in maintaining the normal 
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homeostasis by controlling stores of fat. Leptin also causes reduced food intake, increased 
caloric expenditure and decreased body weight – (often observed as clinical signs of old 
age).59 Therefore, it has been suggested that TNF-α may be a link between fat stores 
regulation and its effects on disease especially in the elderly population. 59  
 TNF-α is thought to have a major role in autoimmune diseases such as rheumatoid 
arthritis and systemic lupus erythromatosus (SLE).20 Increased levels of TNF-α are seen in 
the synovium of affected joints in rheumatoid arthritis.20 Therapies that aim at neutralizing 
the levels of TNF-α in the joints have shown some success in the treatment process. TNF-α 
has an important role in the pathology and treatment of cancer. Muscle wasting seen in 
cancer patients is thought to be due to TNF-α overactivity;23 in lower doses TNF-α is also 
used as a local intratumoral drug. High levels of TNF-α are also seen in nervous 
inflammatory conditions like stroke, meningitis, Alzheimer’s disease and multiple sclerosis. 
23
 In addition to the effects in multiple chronic diseases, increased circulating levels of TNF-
α have been found during infectious diseases states such as malaria and leismaniasis. 23  
 In summary, there are many studies showing elevated levels of IL-1β, IL-6 and TNF-
α during infectious disease conditions. Often levels return to normal after infection is 
resolved. In contrast, increased level of IL-β, IL-6 and TNF-α have been found in multiple 
chronic diseases (diabetes, hypertension, heart disease etc).  In chronic disease states, pro-
inflammatory cytokines may remain elevated. 
 
 
 
  
12 
Acute Exercise and Proinflammatory Cytokines 
 There have been many studies that have looked at the effect of a single exercise 
session on pro-inflammatory cytokines. These studies have generally shown a short-term 
increase in proinflammatory cytokine levels with acute exercise. However, these studies do 
not specifically address the question of whether exercise training can reduce the ‘slightly 
elevated’ level of proinflammatory cytokines associated with chronic disease.  
 
Interluekin-1 (IL-1β) 
 Study by Evans et.al compared the effect of a high intensity single session of 
eccentric exercise on trained and untrained men (45 minutes cycle ergometry at 250 W).30 
There was a 40% increase seen in the plasma IL-1 levels 3 hours after the exercise in all five 
untrained subjects. With the exception of one subject, all other three trained subjects showed 
a reduction in plasma IL-1 levels 3 hours after exercise (the resting levels before exercise 
were higher in the trained group). Therefore one session of strenuous exercise may cause a 
decrease in the levels of IL-1 in endurance-trained men as compared to untrained men. The 
study by Ostrowski et.al on ten young (27.5 years) male trained marathon runners showed a 
significant increase in plasma IL-1β levels immediately after a 3.5 hour race9. Another study 
by Ostrowski et.al on 16 male marathon runners (30.5 years) found a significant increase too, 
in plasma IL-1β levels immediately after the 2 hour race10.  Taken together, these studies 
tend to suggest that exercise potentially resulting in muscle damage (eccentric exercise or 
marathon running) may result in increased plasma IL-1β for some period of time post-
exercise. 
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 Though studies have shown an increase in the level of IL-1β with acute exercise, 
other studies have found no increase or minimal increase. However, there is debate about the 
role of concentric exercise (as opposed to eccentric exercise) on cytokine production. A study 
by Ullum et.al31 on 17 young moderately trained individuals with concentric bicycle 
ergometry exercises (at 75% Vo2 max), showed no change in plasma levels of IL-1β, but the 
levels of IL-1β were below detection limits.  PBMC mRNA for IL-1β also did not change in 
response to exercise.  It is also possible that the type of exercise is important in determining 
the extent to which IL-1β may be altered.  Muscle damaging types of exercise (eccentric 
exercise or marathon running) may result in increased release of IL-1β, whereas exercise that 
does not result in muscle damage may have a different effect or no effect on IL-1β. 
 
Interleukin-6 (IL-6) 
 Acute exercise causes a major transient change in IL-6 levels. Various studies9,32 have 
confirmed a direct increase in the IL-6 levels associated with different intensities of acute 
exercise, there was a increased IL-6 level seen with increased duration and intensity of 
exercise. Two studies by Ostrowski et. al. noted a large increase in IL-6 production 
immediately after a high intensity marathon race. 9,10 In one study10 a marked increase (128 
fold) in the plasma levels of IL-6 in 16 young trained athletes after a marathon was seen. 
Similarly in the other study on 10 trained marathon runners by Ostrowski et al9, the IL-6 
levels increased in the serum 75 fold (and IL-6 mRNA increased in muscle in 5 or 8 runners). 
The acute increase in the IL-6 levels after the marathon was attributed to eccentric nature of 
muscle activity that dominates a marathon race4. The study by Starkie et al36 comparing 
plasma levels of IL-6 in five trained runners after a marathon showed the highest levels 
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immediately after the race. The levels were higher than pre-race values as late as 24 hours 
post exercise. In another study, by Toft et.al32 comparing the effects of acute exercise on 
young and elderly subjects, there was an increase in the plasma levels of IL-6 with lower 
extremity eccentric exercise for 60 minutes in both the groups. The exercise-induced increase 
was less in the elderly compared to the younger subjects. 
 Ullum et.al,31 investigated the effect of acute concentric exercise on plasma levels of 
IL-6. The subjects exercised for 60 minutes at 75% of Vo2 max, of bicycle ergometry (182-
276 W). There was almost an 80% increase in the plasma level of IL-6 in the trained athletes 
(levels of other proinflammatory cytokines remained unchanged). The IL-6 levels returned to 
preexisting levels 1-hour post.  
 Therefore the levels of IL-6 in the body increase drastically with acute exercise. The 
levels are higher in older adults and they increase less in trained versus non-trained 
individuals. The study by Febbraio and Pedersen65 showed that the muscle is the main source 
of increase levels of IL-6 with acute exercise. 
 
Tumor necrosis factor-α (TNF-α) 
 Acute exercise causes a marked increase in the levels of TNF-α. Work by Dufaux and 
Order33 on eight moderately trained young men showed an initial increase in the levels of 
plasma 120 minutes after an endurance run. The higher levels of TNF-α were found 24 hours 
after the 2.5-hour exercise session. Ostrowski et.al9 in the study on 10 male athletes found a 
2.3 fold increase (compared to pre-race levels) in the plasma TNF-α levels at the end of the 
first hour after the marathon. In the other Ostrowski et.al study10 on trained marathon 
runners, the plasma TNF-α levels were 2.5 times higher immediately after the marathon but 
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reduced to twice the pre-race value two hours post. The Starkie study36 showed a two-fold 
increase in plasma levels of TNF-α immediately after the marathon; the values reduced with 
time, but stayed higher than pre-race values 24 hours post. 
 In the Ullum study,31 60 minutes of  concentric bicycle ergometry exercise at 75% 
VO2-max showed no change in the plasma TNF-α levels after the exercise.  Pedersen et. al 
attributed the comparative lower levels of TNF-α after acute exercise to the surged release of 
IL-6. 35  Though IL-6 is considered a pro-inflammatory cytokine it also has some anti-
inflammatory properties. Muscle damage during acute exercise causes release of IL-6 in the 
muscle. This increased release of IL-6 has an inhibitory effect on TNF-α levels.  Therefore, it 
is possible that muscle-damaging types of exercise have the greatest impact of TNF-α, 
similar to the findings with respect to IL-1β34. 
 The cytokine response to exercise appears to be dependent upon the duration and the 
type of exercise. Of the six studies looking at the effect of acute exercise on proinflammatory 
cytokines, all six showed an increase in the levels of IL-6 after exercise, and three of the four 
showed increased levels of IL-1β.  Of the four studies on TNF-α, two showed no increase 
with acute exercise (refer table 1). Therefore the effect of acute exercise on cytokine levels is 
variable due to undetermined factors. 
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Table 1.  Previous studies on effects of acute exercise on proinflammatory cytokine level. 
Study Duration Subjects /protocol Cytokine Results 
Ostrowski  
et al9 Single marathon 
10 male runners (24-37 
years old) 
Plasma IL-6, 
TNF-α, IL-1β, 
IL-10 
Increase in plasma levels: 
128 fold - IL-6, 2.1 fold - 
IL-1β, 2.3 fold - TNF-α and 
27 fold - IL-10 
Ostrowski 
et.al10 Single marathon 
16 trained marathon runners 
(30 years) 
Plasma IL-6, 
mRNA for IL-6 
and IL-1β 
90 fold increase in plasma 
levels of IL-6, almost 3 fold 
increase in IL1RA levels. 
Evans et 
al30 
45 minutes cycle 
ergometry  (250W)  
4 male trained runners  5 
untrained men 
Plasma IL-1, 
creatine kinase 
47% increase in plasma 
levels of IL-1 and 56% 
increase in the CK levels in 
the untrained. 
Ullum et 
al31 
60 min. bicycle 
ergometry (75% Vo2 
max) 
17 trained men (23-39 
years) 
Plasma: IL-6, 
IL-1ά, IL-1β 
and TNF-α 
70% increase in plasma 
levels of IL-6, no change in 
IL-1ά, IL-1β and TNF-α 
levels 
Toft et al32 60 min. cycle 
ergometry 
10 elderly (67-75 years) and 
10 young subjects (20-27 
years) 
Plasma IL-6 and 
TNF-α 
No effect of exercise on 
TNF-α levels; eight fold 
increase in IL-6 in the 
younger adults, only two 
fold increase in the elderly. 
Starkie et 
al36 Single marathon  5 male trained runners 
Plasma IL-6 and 
TNF-α 
40% increase in plasma 
levels of TNF-α, IL-6 levels 
increased 200%.  
 
Chronic Exercise and Proinflammatory Cytokines 
 There have not been many studies investigating the role of long-term (chronic) 
exercise on cytokine levels. The long-term studies can be broadly classified as intervention 
studies (divided here as aerobic or resistance training) and epidemiological studies. 
Epidemiological studies are classified as those studies without a direct exercise intervention. 
Chronic studies are categorized as having duration of at least 12-weeks of intervention. 
 
Interventional studies 
 Cardiovascular exercise 
 Smith et al17 investigated the effects of 6 months exercise of training in 43 middle-
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aged people. The subjects performed weight training, walking, cycling, stretching, aerobics, 
rowing and climbing exercises as part of this study, exercising 2.5 hours per week. Almost 
35% of the subjects lost weight (average weight loss was 3.3%) at the end of 6 months of 
supervised physical activity. There was a reduction in the proinflammatory cytokine levels 
produced by PHA stimulated peripheral blood mononuclear cells. The study showed almost a 
59% decrease in IL-1β and TNF-α levels. 
 The three-year multidisciplinary by Esposito et al study37 assessed the role of physical 
activity and a Mediterranean diet in reducing proinflammatory cytokine levels in 120 obese 
middle-aged premenopausal women. As part of the two-year intervention, the subjects were 
advised about diet and physical activity. The activity levels were charted using a 
questionnaire. There was a reduction seen in serum CRP and IL-6 levels at the end that 
correlated with reduced BMI levels. Although physical activity played an important role, the 
reduction in IL-6 and CRP was attributed to more than one factor in the study.  
 Baum et.al37 found an increase in the amount of IL-1β and IL-6 produced by PBMC 
after exercise training for 12 weeks. Eight healthy adults ran 30 km, 3 times/week, whereas 7 
control subjects did not exercise. There was an increase in IL-1β and IL-6 levels in PBMC 
after 12 weeks, found in the subjects that ran as compared to controls . 
 Reynolds et. al43 examined the effect of aerobic exercise on six months of aerobic 
exercise 14 elderly hypertensive women. The women performed aerobic exercise for 6 
months, consisting of treadmill walking, stair-climbing and stationary cycling. At the end of 
six months, the exercises were performed for 40 minutes each day, three days per week. The 
intensity was at 75-80 % HRR. There was a decrease in body fat levels, but no changes in 
plasma TNF-α levels, after exercise.  
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 Resistance/endurance training 
 The Greiwe study38 evaluated the effect of a 12-week resistance training program on 
muscle TNF-α level in 12 elderly subjects over 75 years. The experimental subjects exercised 
using machines, while the control group did light callisthenic exercises. After 12 weeks there 
was a reduction in the levels of TNF-α in the muscle tissue (measured at rest).  
 Rall et al41 compared the effects of progressive resisted exercises on 3 groups of 
subjects; elderly, young and patients of (rheumatoid arthritis) (RA). The elderly subjects 
were randomly divided into either the strength or non-strength group. The RA group, the 
elderly strength group and the young subjects exercised at an intensity of 1repetition 
maximum (RM).  One RM is the maximum amount of weight that can be lifted by a subject 
once through the full range). on trunk and lower extremity machines; totaling about 8 
repetitions per sets, 3 sets per session performed twice weekly at approximately 45 minutes 
per session. The elderly non-strength group did not exercise and served as controls. The 
production of IL-1β, IL-6 and TNF-α by PBMC were measured and no change in PBMC 
cytokine levels after 12-weeks of exercise were found.  
 Mattusch et.al, measured the CRP levels in 12 moderately trained young runners (25-
40 years) over a 9 month period.53 The subjects exercised 3-4 times per week for a duration 
of 50 minutes. Although there was an increase in the intensity of exercise over time (31 km/ 
week to 53 km/week over nine months), there was a decrease in the CRP levels in plasma for 
10 out of 12 runners measured, at the end of the training session.  
 Taken together, the limited data from intervention trials appears to be inconclusive. In 
general, studies employing weight training as the primary type of exercise did not observe 
effect on serum cytokines or cytokine production by PBMC’s.  However, weight training 
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exercise did appear to alter TNF-α production in the muscle tissue.  With respect to studies 
using aerobic exercise as the primary type of activity, it appears that serum cytokines or 
PBMC production of cytokines is reduced if the duration of the training program was longer 
term (greater than 6 months).  Weight loss may also be a factor in these longer term aerobic 
intervention studies. 
 
Epidemiological studies 
 There have not been many epidemiological studies that assessed the effects of 
physical activity. The study by Shinkai et. al.40 compared the plasma levels of 
proinflammatory cytokines IL-1β and IFN-γ in PBMC. There was no difference in the levels 
of these cytokines in between the habitual elderly runners and the sedentary controls. The 
study by Pischon et al13 on 405 healthy men and 454 healthy women showed an inverse 
relationship between physical activity and inflammatory markers. There was a decrease in 
the plasma levels of TNF-α and IL-6 with unsupervised physical activity; this association 
was greater in subjects with lesser body fat. Pradhan et al25 examined the plasma cytokine 
levels of IL-6 in 188 patients of DM and 362 disease-free controls. Higher levels of IL-6 and 
CRP were found in subjects that had DM. There was a direct relationship between disease 
levels and IL-6 levels. They also exercised less and had greater body mass indices. 43% of 
the subjects rarely exercised, 26 % exercised once a week, 25 % exercised 1-3 times a week 
and about 5 % exercised greater than 4 days a week. A cross sectional study by Colbert et. 
al16 examined the association between physical activity and inflammatory markers. 3075 
healthy men and women (between 70 and 79 years) completed a questionnaire about physical 
activity (gardening, housework, walking, weight training etc.) over the previous 12 months. 
  
20 
CRP and IL-6 (serum) and TNF-α (plasma) levels were measured. There was an18% 
reduction in IL-6 levels and an 8% reduction in plasma TNF-α levels with >180 min. per 
week. The CRP levels were reduced by 17% with the same exercise over the same time 
period. There was an inverse relationship between inflammatory markers and exercise levels. 
When BMI was accounted for, this effect was still consistent across different body types in 
the study. 
 There have not been any studies greater than 6 months duration that have assessed the 
effect of aerobic exercise, and proinflammatory cytokines in older adults.  It is important to 
determine whether age-associated elevations in serum cytokine levels may be reduced by an 
exercise intervention.  The information may have clinical relevance and may provide 
additional insight into the mechanisms by which exercise reduced the risk of multiple chronic 
diseases. 
  
21 
Table 2.  Previous studies on effects of chronic exercise (>12weeks) on proinflammatory 
cytokine levels. 
 
Study Duration Subjects/protocol Cytokine Results 
Smith et al17 
6 months exercise 
(2.5hours per week, 
70 min/ session) 
52 men and 18 men 
(mean: 48.5 years).  
PBMC  IL-1α, 
TNF-α, IFN γ, IL-
4, IL-10, serum 
CRP 
Reduction in PBMC IL-1α 
(3%), TNF-α (28%) 
 IFN γ (44%)   
 
Esposito et al38 
2 years, diet and 
physical activity, 
Questionnaire  
120 premenopausal 
women  
Serum IL-6, IL-18, 
CRP 
35% reduction in IL-6 and 
25% reduction CRP levels 
Greiwe et.al39 
12-week resistance 
training (50-90 min/ 
day, 3 times a week) 
12 elderly and 12 
young untrained 
elderly adults, 5 
elderly controls 
TNF-α in muscle 
28% reduction in TNF-α 
levels 
 
Baum et.al40 
12-weeks of 
endurance exercise 
(3-5 hours/week, 3 
times a week) 
4 men and 4 women 
(mean age: 42 years)  
Plasma IL-1β, IL-
2, IL-6 and IFN γ 
42% increase in levels of 
IL-1β and 11% increase in 
IL-6 levels 
 
 Rall et al42 
12 weeks of PRE. 
3 sets per session 
twice/ week 
8 subjects with RA, 8 
young healthy and 8 
elderly healthy 
Plasma IL-1α, IL-6 
and TNF-α 
PBMC cytokine levels did 
not change 
Reynolds et.al44 6 months 3 days per week 
14 older hypertensive 
women, 75% of Vo2 
max  
Plasma TNF-α No change in levels  
 
 
 
 
 
 
 
 
 
Table 3. Previous epidemiological studies (no exercise intervention) and the effect on 
proinflammatory cytokine levels. 
 
Study Type of study Subjects/protocol Cytokine Results 
 Pischon et al13 Questionnaire  405 men and 454 women  IL-6, TNF-α and CRP 
Inverse relationship seen 
 with physical activity 
Pradhan et al26 Questionnaire  188 women (DM) and 362 (disease free control) IL-6 and CRP 
Increased levels of IL-6 and 
CRP.  
Shinkai et al40 Questionnaire  
17 elderly, 16 younger 
runners and 19 elderly 
controls 
Plasma IL-1β,  
IL-2, IFNγ, IL-4 
No change in IL-1β or IFN-γ 
levels.  
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CHAPTER 3. HYPOTHESIS AND METHODS 
 
Hypothesis 
 I hypothesized that the levels of IL-1β, TNF-α, IL-6 produced by LPS-stimulated 
peripheral blood mononuclear cells and IL-6 in serum would decrease with long-term aerobic 
exercise training to a greater extent than with a strength/flexibility exercise training program. 
 
Methods 
Subjects 
 Subjects were healthy individuals over 64 years of age. The study was approved by 
the Institutional Review Board (IRB) of Iowa State University. All subjects completed a 
medical history form and participants with conditions that may interfere with the immune 
response were excluded (e.g autoimmune disorders, cancer within the previous five years 
etc.). Any subject taking medication that may have altered the immune response such as oral 
corticosteriods and non-steroidal anti-inflammatory drugs were also excluded. Subjects 
(n=50) were randomly assigned to an aerobic exercise or a flexibility / strength group (25 
participants per group). A log was maintained for attendance and adherence to the exercise 
protocol for both groups. 
 Initially there were 12 females and 13 males in the CARDIO group and 10 females 
and 15 males in the FLEX group; by the end of the intervention there were 20 subjects in the 
CARDIO and 22 subjects in the FLEX group. A study timeline is shown in Figure 1. 
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Pre and post testing 
 The baseline testing included a physician supervised maximal exercise treadmill test, 
the Standard Senior Fitness tests (Rikli and Jones 2001) and a diet survey to chart nutritional 
habits or deficiency (Block 98 Food Survey). Skin-fold measures were taken before and at 
the end of the study at ten sites; the results from the Jackson Pollock and Durnin Wornesky 
equations were averaged to calculate body fat. 63 Body Mass Index (BMI) was also measured 
using the following equation – 
                                                   BMI =  (Weight in pounds)    x   703 
                                                                (Height in inches)2 
 
 
 
Figure 1.  Timeline for study  
 
Apart from the initial medical history taking, the Pre-Tests* included: 
1. Physician supervised graded maximal exercise test 
2. Fitness testing – Senior Fitness Test (Rikli/Jones) 
3. Body Fat/weight measurements 
The pre-tests were followed by blood draws I (after Blood I the subjects began their 
participation in either the CARDIO or FLEX groups). At the end of the 10-month exercise 
period, blood draw II was performed. This was followed by Post Tests** which again 
included 
1. Fitness testing -  Senior Fitness Test (Rikli/Jones) 
2. Body fat/weight measurements 
Pre-
Tests* 
Cardio  
Flex 
Blood I
  
Blood II
  
Post 
Tests** 
10 months 
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Exercise intervention  
 Cardiovascular (CARDIO) group 
 The CARDIO group initially exercised at 45-55% of the heart rate reserve (HRR) and 
then gradually progressed to 75% of HRR. The group met three times a week, performing 
exercise in the target heart rate zone for 25-30 minutes every session, over a 10-month 
intervention period. The initial warm-up consisted of 10 minutes of stretches and walking 
and the cool-down at the end consisted of stretches, walking, and some toning exercises. The 
exercise attendance, target heart rate and adherence to protocol were monitored for all 
participants.  
 Flexibility and strengthening (FLEX) group 
 The FLEX group performed flexibility, balance and toning exercises for the first 6 
months. During the last four months of the intervention, light strength training exercises were 
added to the routine, averaging one set of 12-15 repetitions per workout (at an estimated load 
ranging from 50-80% of 1 RM). The exercise sessions began and ended with a warm-up and 
ended with a cool-down session of 10 minutes; the exercise lasted 25-30 minutes each 
session (not including warm up and cool-down). The stretching and strengthening exercises 
included all major upper and lower extremity muscle groups such as pectorals, latissimus 
dorsi, trapezius, quadriceps, hamstrings and gluteal stretches. Free exercises using a wobble 
board and therabands were used. The machines used for strengthening were the military 
press, Latissimus pull down, seated chest press, upper back, arm curl, triceps, lower back, 
abdominals, leg curl and leg extension.  
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Laboratory methods 
 Blood was collected at two points in the experiment - before and after the 10-month 
intervention period. Blood collection was performed at least 24 hours after exercise; the 
blood draws were scheduled so that the acute effect of exercise did not affect the sample 
drawn. PBMC were isolated by centrifugation over Ficoll-Paque Plus (Amershan Pharmacia 
Biotech, Piscataway, NJ) and adjusted to 4x106 cells/ml in AIM-V medium (Life 
Technologies, Grand Island, NY). ELISA kits (BD Bioscience Pharmacia) were used to 
measure the cytokines following the protocol supplied by the company. Supernatant was 
collected from peripheral blood mononuclear cells (PBMC) after 24 hours of incubation with 
100 ng/ml lipopolysaccharride (LPS) at 37◦ C, 5% Co2 in a humidified atmosphere and 
frozen at -80oC until analysis of IL-1β, TNF-α and IL-6. IL-6 was measured both in the 
serum and PBMC. Serum was collected and frozen at -80ο C for assay by high sensitivity 
ELISA. 
 Briefly, the wells of 96 well microtiter plates were coated with capture antibody and 
incubated overnight. After three washes, the wells were coated with assay diluent (blocking 
buffer). Supernatant samples were added along with the standards. After a two hour 
incubation, the detection antibody was added to each well. Lastly, substrate solution was 
added and after 30 minutes of incubation the absorbance was read at 655 nm using a 
microplate reader (Biorad).  
 
Statistics 
 A mixed Analysis of Variance (ANOVA) was tested for effects of group 
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(cardiovascular or strength/flex groups) and time (pre versus post) was used to compare the 
differences in IL-1β, TNF-α and IL-6. Body weight was included as a covariate in the model.  
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CHAPTER 4.  RESULTS 
 
Weight Change as a Covariate 
 The change in body weight was entered in all models and was not a significant factor 
in any of the models with respect to the change in cytokine levels. The data shown in the 
figures 2, 3, 4 and 5 reflect the results of the model when weight was included as a covariate. 
Overall there was a trend (p = 0.10) towards a reduction in body weight over time. (Table 4) 
There was a significant effect of time with respect to BMI such that both groups decreased at 
the post intervention time point (t =0.006) (Table 4). 
 
Physical Activity Measures 
 A significant improvement was observed in both treatment groups for the ‘chairstand’ 
and the ‘sit and reach’ activity (Table 4). The chairstand is a measure of lower extremity 
strength and endurance. Similarly, the sit and reach, is a measure of the flexibility of the 
subject. With respect to the 6-minute walk test as a measure of aerobic fitness, the cardio 
group performed better than the flexibility group over time (significant treatment by time 
interaction). There was no significant difference seen between groups with respect to the 
other physical activity variables (Table 4). 
 
Cytokines in PBMC Cultures 
 There was a reduction seen in the levels of IL-1β produced by LPS stimulated PBMC 
in both the groups after the ten-month intervention (significant main effect of time; Figure 2, 
p<0.05). 
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 With respect to IL-6 produced by LPS-stimulated PBMC, there was a reduction in the 
in the CARDIO group, and an increase in the FLEX group as suggested by the significant 
time by treatment interaction (p = 0.037; Figure 3). Unlike IL-6 and IL-1β, TNF-α 
production by PBMC was not altered by the intervention (no significant treatment, time or 
treatment by time effects; Figure 4, P<0.05) 
 
Serum Cytokine 
 The only cytokine measured in the serum was IL-6.  Serum levels of IL-6 were also 
not significantly changed by the intervention (no main effect of treatment, time, or treatment 
by time interaction; Figure 5).  However, there was a trend towards reduced IL-6 in the 
CARDIO group (p=0.11). 
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 Figure 2.  IL-1β concentration pre and post exercise (mean + S.E). 
    LPS-stimulated IL-1β by PBMC from subjects in the CARDIO group as compared to the 
FLEX group prior to the intervention (PRE) and following the intervention (POST). A 
significant main effect of time (P<0.05) was observed such that IL-1β decreased in both 
groups following the intervention. (N= 25/group) 
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Figure 3.  IL-6 concentration pre and post exercise (mean + S.E). 
 LPS-stimulated IL-6 by PBMC from subjects in the aerobic exercise group as compared to 
the flex group prior to the intervention (PRE) and following the intervention (POST). A 
significant treatment by time was observed (p<0.05) such that IL-6 was lower in the 
CARDIO group, but not the FLEX group following the intervention. (N = 25/group) 
 
  
31 
 
 
0
50
100
150
200
250
300
350
400
450
500
PRE POST
n
g/
m
l Cardio
Flex
 
Figure 4.  TNF-α concentration pre and post exercise (mean + S.E). 
 LPS-stimulated TNF-α by PBMC from subjects in the cardio group as compared to the flex 
group prior to the intervention (PRE) and following the intervention (POST), No significant 
changes were observed (N = 25 / group) 
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Figure 5.  IL-6 concentrations in the serum pre and post exercise (mean + S.E).  
 No significant changes were found. Treatment by time interaction, p=0.11 
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Table 4. Physical activity measures for the subjects in the CARDIO and FLEX group. 
 
 Physical Activity 
variables 
Mean PRE (Std. deviation) Mean POST (Std. deviation) 
  CARDIO FLEX CARDIO FLEX 
CHAIRSTAND 16.65 (4.9) 16.88 (3.8) 18.3* (7.6) 20.16* (5.0) 
Lt. ARM CURLS 22.31 (4.1) 19.1 (8.5) 22.36 (4.7) 21.84 (4.0) 
6 MIN. WALK 674.36 (124.7) 686.68 (87.4) 768.73** (159.7) 738.39 (161) 
STEPS 102.44 (34.9) 104.29 (32.1) 108.83 (19.0) 112.05 (26.5) 
SIT AND REACH -0.16 (5.3) -0.95 (5.0) 2.56* (4.9) 0.69* (5.0) 
BACK SCRATCH -3.02 (3.7) -4.02 (3.6) -2.46 (5.2) -3.83 (4.2) 
UP AND GO 4.92 (0.88) 5.05 (1.1) 4.41 (0.73) 4.54 (1.2) 
BODY WEIGHT 164.7 (32.9) 173.7 (35.8) 161.8 (31.9) 172.5 (35.7) 
BMI 28.4 (3.2) 26.8(4.7) 28.1 (3.7) 25.8 (3.8) 
 
* p< 0.01 vs. PRE 
** Treatment by time interaction such that CARDIO increased at POST compared to 
PRE, but FLEX did not change.  
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CHAPTER 5.  DISCUSSION 
 
 In this study, I found a statistically significant association between chronic exercise 
training and reduction in cytokine levels. To our knowledge, this is the first study that has 
examined the effects of a long term (10-month) exercise intervention on pro-inflammatory 
cytokine levels among older adults. We observed that aerobic exercise decreased the level of 
both IL-6 and IL-1β produced by PBMC whereas resistance training altered the level of only 
one cytokine, IL-1β.  Although the serum cytokine levels of IL-6 were not statistically 
different between groups after the intervention, there was is a trend towards reduced serum 
IL-6 in subjects performing the aerobic exercise. Taken together, these findings suggest that 
cardiovascular exercise may be a better exercise modality than strength and flexibility 
training in altering the cytokine levels. 
 
Proinflammatory Cytokines and Aerobic Exercise 
Intervention studies 
 There have not been any other long-term interventional studies that have compared 
aerobic training and resistance training with respect to their effects on proinflammatory 
cytokine levels in the elderly. Our results are comparable to other interventional studies that 
evaluated chronic aerobic exercise and proinflammatory cytokine levels in adults of younger 
age groups.  Another study with younger subjects (mean age 48 years) observed a significant 
reduction in mitogen-stimulated PBMC production of IL-1α, TNFα, and IFNγ after a 6 
month exercise intervention.17 Although I did not assess IL-1α, we did find a significant 
decline in mitogen-induced production of IL-1β in both exercise groups and a reduction of 
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another proinflammatory cytokine, IL-6 (only in subjects performing aerobic exercise).  A 
more recent study with coronary heart disease patients also observed that 12 weeks of aerobic 
exercise reduced plasma concentration of IL-1, IL-6, and CRP. 64 This study lends further 
support to the concept that exercise has anti-inflammatory actions.  Although our study only 
observed a trend towards reduced serum IL-6, it is possible that the magnitude of the 
decrease was greater in the recent study by Goldhammer et al., because their subject pool 
included only coronary heart disease patients (that are likely to have higher levels of 
proinflammatory cytokines at the onset of the study).  One other study in older females 
(mean age = 62) failed to find a significant effect of an aerobic exercise intervention on 
serum TNF-α, similar to our results with respect to mitogen-induced TNF-α 43. Although 
epidemiology studies tend to suggest that TNF-α is decreased with increasing activity, it is 
possible that the effect is small and a greater number of subjects or a longer period of 
exercise intervention is required to detect a  significant difference.   
 In a separate intervention trial of obese women, a 2 year diet/exercise program 
resulted in decreased serum levels of IL-6, and CRP37.  Significant weight loss occurred in 
this study, but significant weight loss did not occur in our subjects.  It is possible that the 
trend we observed with respect to reduced IL-6 might have been statistically significant if 
weight loss had occurred.  The authors of the weight loss study measured adiponectin and 
showed an inverse relationship between IL-6 and adiponectin, suggesting that the two may 
influence each other.  Unfortunately, we did not measure adiponectin, but in future studies it 
would be important to determine whether a long-term exercise program without significant 
weight loss would alter adiponectin.  Adiponectin is a protein that is produced by adipose 
tissue, and a separate study by Engeli et.al46 also showed an inverse relation between 
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adiponectin levels and IL-6 in obese women. Esposito et.al., differed from our study in that 
(1) the subjects were obese (2) the subjects followed a diet plan (3) greater number of 
subjects (4) longer duration of intervention and (5) significant weight loss by subjects.  Given 
these differences in study design, the combination of exercise, diet, and weight loss may have 
a greater impact on serum IL-6 then exercise alone.  
 One study with younger adults actually observed an increase in production of IL-1β 
in mitogen stimulate whole blood cultures following a 12 week aerobic exercise intervention 
(Baum)39.  It is not clear why an increase was found in this study, since most other studies 
tend to find a decrease of inflammatory cytokine production.  Whole blood cultures were 
used instead of isolate PBMC and it is possible that something present in the whole blood 
after exercise training influenced the production of IL-1.  Also, the subjects performed 
moderate to vigorous exercise 3-5 hours per week (substantially more than that performed in 
most other exercise intervention trials).  It is possible that higher intensity, longer duration 
exercise training has a different effect on proinflammatory cytokine production.  Perhaps 
tissue damage occurred as a result of the training program which may have resulted in 
increased production of inflammatory mediators.  Future studies are needed to tease out the 
different effects of moderate exercise as compared to strenuous exercise on inflammatory 
mediators.   
 Interestingly, another exercise study by Greiwe, et al.,38 found a reduction in TNF-α 
in muscle tissue following a 3 month resistance exercise program in older adults.   Although 
we did not observe a significant decrease in TNF-α production by LPS-stimulated PBMC, it 
is possible that if we had examined TNF-α in the muscle, we may have found a change.  
Perhaps exercise-induced changes in TNF-α are tissue specific, and a longer duration of 
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exercise may be necessary to detect a change in PBMC expression of TNF-α as compared to 
TNF-α expression in muscle tissue.  Another potential explanation may be related to the 
intensity of the strength training performed. The Greiwe study included supervised resistance 
exercises were performed (3 times a week for 3 months; ~ 90 minutes) at an intensity up to 
100% 1 RM, an intensity much greater than our study. Also, the participants in the 
intervention group were much older (82 + 1) than subjects in our study. This age difference 
may have caused a greater difference in TNF-α values (Aging is associated with greater 
decrease in muscle mass that may correlate with a higher TNF-α level). In future studies, it 
may be helpful to examine any potential correlation between TNF-α expression in muscle 
tissue and TNF-α in PBMC.  Finally, one other study specifically examined the effect of 
strength training exercise on cytokine levels in both disease (Rheumatoid Arthritis, RA) and 
healthy individuals, but failed to find an effect of exercise on cytokine level.41 This study was 
much shorter in duration (only 12 weeks) and more importantly, serum levels of the 
cytokines were not detectable likely due to the fact that high-sensitivity kits were not 
available when this study took place.    
 
Epidemiological studies 
 Most of the results of the epidemiological studies are consistent with the findings 
from our study. In the Pischon et al13 study of over 850 healthy men and women of all ages, 
there was an inverse relationship between physical activity and proinflammatory cytokine 
(plasma IL-6, CRP and soluble TNF-receptor (sTNF-R) level. In our study, there was a 
reduction in the IL-6 values with cardiovascular exercise, a trend towards reduced serum IL-
6, and a reduction in IL-1β in both the cardiovascular and flexibility/strength groups, 
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supporting the inverse association found between physical activity and serum cytokines in 
the study by Pischon et al.  Similarly, in a study of 3,075 individuals in an age group more 
similar to that of our study (aged 70-79), found that higher levels of exercise were associated 
with decreased levels of serum CRP or plasma IL-6 and TNF-α.  In both of these 
epidemiological studies, adjusting for body fatness or mass attenuated the effect of physical 
activity.   
 Our results differed from the results of the Shinkai et al study.40 The Shinkai et al 
study compared the effect of regular running on proinflammatory cytokine levels.40 There 
was no difference in the IL-1β levels (in PBMC) between the elderly regular runners and the 
older sedentary controls. Though the physical activity was unsupervised, the experimental 
subjects had exercised 2-3 days/week for an average of 10 years before the study. One of the 
reasons for the apparent similarity in IL-1β between the two groups may be because it was 
not a longitudinal study. As with other cross-sectional comparisons, though they help 
compare across populations, they do not prove causation.   
 
Body weight 
 By measuring the body weight, we determined the extent to which changes in weight 
might contribute to the changes in IL-6 levels. Though IL-1β, IL-6 and TNF-α are produced 
by adipose tissue, only IL-6 is released into the bloodstream.51 Weight loss leads to reduction 
in the fat stores and therefore, IL-6 serum levels decrease. I observed a trend towards weight 
loss in both groups in our study at the post time point compared to the pre time point; 
although this was not statistically significant.  Also, when body weight was included as a 
covariate in the model, the effect of exercise remained (independent of body weight).   
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 The molecules leptin and adiponectin may have a role in exercise related alterations 
in proinflammatory cytokines.45 These molecules are produced by adipose tissue.45 Higher 
levels of leptin are found in obese individuals, and leptin levels decrease with weight loss. 
Leptin also signals the hypothalamus with fat level and nutritional states, which further 
modulates food intake and energy expenditure. Leptin has inflammatory properties and 
stimulates (and is stimulated by) proinflammatory cytokine production. The molecule 
adiponectin, is also secreted by adipose tissue, but is inversely proportional to adipose tissue 
levels. Higher body weight is associated with lower levels of adiponectin. Adiponectin 
inhibits TNF-α production and is considered to have has anti-inflammatory properties, by 
inhibiting proinflammatory cytokine production. 
 The leptin-adiponectin ratio may have a role in altering body weight measures. 
Higher or unchanged levels of adiponectin are related with weight loss due to exercise.55 
Weight loss due to exercise also decreases leptin levels in obese individuals.55 Study by Ross 
et al55 shows that exercise without weight loss may decrease visceral fat in obese men, which 
produces leptin. Therefore exercise may alter plasma leptin and adiponectin levels even 
without changes in body weight (but potentially through reductions in visceral fat).  An 
exercise-induced modulation in the leptin-adiponectin ratio independent of changes in body 
weight may explain the trend towards a reduction in the plasma IL-6 levels with 
cardiovascular exercise observed in our study. In future exercise intervention studies, it 
would be worthwhile to examine leptin and adiponectin to determine the extent to which 
alterations in the levels of these hormones may influence cytokine levels (with and without 
weight loss).  
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Antioxidants 
 Regular exercise helps increase the antioxidant defenses reducing stress associated 
with tissue injury and exercise.58 There is increased consumption of oxygen by the tissues 
with acute exercise; increased tissue oxygen consumption is related to increased production 
of free oxygen radicals. Antioxidants produced naturally by the body help reduce free oxygen 
radical induced damage. However higher levels of free oxygen radicals produced due to the 
oxidative stress of exercise may alter the normal  Previous studies have shown the role of 
for antioxidants in attenuating the release of proinflammatory cytokine.49,58,66  Work by 
Powers et al42 showed the beneficial effect of exercise in increasing antioxidant levels, 
potentially lowering the inflammatory response. A study by M. De La Fuente58 showed 
higher levels of antioxidant molecules like vitamin C and E in peripheral blood neutrophils as 
compared to sedentary controls, after graded exercise. Study by Laughlin et. al and Powers 
et.al., show sustained exercise cause greater adaptive response and resistance to oxidative 
damage, leading to greater oxidative capacity in the tissue. Therefore, it is possible that 
exercise via increases in anti-oxidant defenses leads to reduction of inflammatory factors. 
 Aging is associated with an increase in the resting free oxygen radical levels. Aging is 
also associated with reduced immune functions.  A study by Vassilakapoulos et.al49 showed 
that concentric exercise helped improve antioxidant levels more than eccentric and mixed 
exercise65, in turn reducing proinflammatory cytokine levels. The subjects exercised for 45 
min. at 70% VO2 max. The cytokines were measured in plasma and were lower after 
antioxidant ingestion. Therefore, similar to younger adults, moderate chronic exercise may 
have a role in improving antioxidant response, leading to reduced pro-inflammatory 
cytokines in elderly individuals. 
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Summary 
 Long-term cardiovascular exercise or flexibility/strength appears to reduce the levels 
of LPS-induced PBMC production of IL-1β.  In contrast, only cardiovascular exercise 
appears to have an effect on serum IL-6 (trend) and PBMC production of IL-6.  The 10-
month exercise did not alter the levels of proinflammatory cytokine TNF-α in any of the 
exercise groups. Our results suggest that cardiovascular exercise may have a greater anti-
inflammatory effect as compared to flexibility/strength exercise in older adults. Our findings 
also suggest that long term exercise (nearly one year) may also retard the inflammatory 
effects of aging. As aging may be associated with chronic diseases that increase 
proinflammatory cytokine levels; it is possible that an improved antioxidant response 
resulting from cardiovascular exercise has a protective effect with respect to reduction of 
inflammatory cytokines.  However, the actual mechanism by which exercise results in a 
reduction of inflammatory mediators remains to be identified.  A significant reduction of 
inflammatory cytokine level by exercise may therefore lead to a decreased risk of multiple 
“inflammatory” chronic disease states. 
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